Edson Moore Healthcare Ventures (EMVH) grows innovative healthcare companies through investment and the delivery of resources and guidance.
EMVH was formed in September, 2002, to acquire a $148,000,000 portfolio of drug delivery and pharmaceutical securities previously owned by Elan Pharmaceuticals.
EMVH seeks superior venture capital returns by supporting the development of its portfolio companies, and adds value by making follow on investments, serving on the Boards, and seeking to facilitate partnerships with other pharmaceutical companies.
Chromos Makes Payment on Debenture »Read More
|
